Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Semaglutide (Novo Nordisk) in Diabetes Mellitus, Type 2: NCT07732218 Clinical Landscape Report 2026
28 September 2026
NCT07732218 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sintilimab in Locally Advanced Rectal Carcinoma: NCT07738042 Clinical Landscape Report 2026
28 September 2026
NCT07738042 clinical landscape for Locally Advanced Rectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Benzydamine Hydrochloride in radiation oral mucositis: NCT07748442 Clinical Landscape Report 2026
28 September 2026
NCT07748442 clinical landscape for radiation oral mucositis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nivolumab in Squamous Cell Carcinoma of Head and Neck: NCT07741565 Clinical Landscape Report 2026
28 September 2026
NCT07741565 clinical landscape for Squamous Cell Carcinoma of Head and Neck: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
Ketamine Hydrochloride in Laryngeal Neoplasms: NCT07746115 Clinical Landscape Report 2026
28 September 2026
NCT07746115 clinical landscape for Laryngeal Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Hypopharyngeal Carcinoma: NCT07752394 Clinical Landscape Report 2026
28 September 2026
NCT07752394 clinical landscape for Hypopharyngeal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Finotonlimab in Squamous Cell Carcinoma of Head and Neck: NCT07751276 Clinical Landscape Report 2026
28 September 2026
NCT07751276 clinical landscape for Squamous Cell Carcinoma of Head and Neck: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
Semaglutide (Novo Nordisk) in Alcohol Use Disorder: NCT07772960 Clinical Landscape Report 2026
28 September 2026
NCT07772960 clinical landscape for Alcohol Use Disorder: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Obesity: NCT07754045 Clinical Landscape Report 2026
28 September 2026
NCT07754045 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PP03A in Obesity: NCT07777575 Clinical Landscape Report 2026
28 September 2026
NCT07777575 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zenagamtide in Weight Loss: NCT07757087 Clinical Landscape Report 2026
28 September 2026
NCT07757087 clinical landscape for Weight Loss: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Oliceridine fumarate in Obesity: NCT07759778 Clinical Landscape Report 2026
28 September 2026
NCT07759778 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.